These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 15838282

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Protective effects of a dual endothelin converting enzyme/neutral endopeptidase inhibitor on the development of pulmonary hypertension secondary to cardiac dysfunction in the rat.
    Dai ZK, Hsieh CC, Chai CY, Wu JR, Jeng AY, Chou SH, Wu BN, Yeh JL, Chen IJ, Tan MS.
    Pediatr Pulmonol; 2010 Nov; 45(11):1076-85. PubMed ID: 20658482
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11.
    Fink CA, Qiao Y, Berry CJ, Sakane Y, Ghai RD, Trapani AJ.
    J Med Chem; 1995 Dec 22; 38(26):5023-30. PubMed ID: 8544178
    [Abstract] [Full Text] [Related]

  • 26. Effects of a selective neutral endopeptidase and a nonselective neutral endopeptidase/endothelin-converting enzyme inhibitor on lipopolysaccharide-induced endotoxaemia in anaesthetized Sprague-Dawley rats.
    Pham D, Jeng AY, Escher E, Sirois P, Battistini B.
    J Cardiovasc Pharmacol; 2000 Nov 22; 36(5 Suppl 1):S362-6. PubMed ID: 11078421
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitors.
    Jullien N, Makritis A, Georgiadis D, Beau F, Yiotakis A, Dive V.
    J Med Chem; 2010 Jan 14; 53(1):208-20. PubMed ID: 19899765
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM, Kemp PA, Brunner-Ferber F, Bennett T.
    Br J Pharmacol; 1997 Dec 14; 122(8):1687-93. PubMed ID: 9422815
    [Abstract] [Full Text] [Related]

  • 32. Rat big endothelin-1-induced bronchoconstriction and vasoconstriction in the isolated perfused rat lung: role of endothelin converting enzyme and neutral endopeptidase 24.11.
    Held HD, Raschak M, Uhlig S.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 May 14; 355(5):619-24. PubMed ID: 9151301
    [Abstract] [Full Text] [Related]

  • 33. Attenuation of puromycin aminonucleoside-induced glomerular lesions in rats by CGS 26303, a dual neutral endopeptidase/endothelin-converting enzyme inhibitor.
    Feldman DL, Mogelesky TC, Chou M, Jeng AY.
    J Cardiovasc Pharmacol; 2000 Nov 14; 36(5 Suppl 1):S342-5. PubMed ID: 11078415
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive rats.
    Webb RL, Abramson ML, Beil ME, Odorico LM, Chatelain RE.
    J Cardiovasc Pharmacol; 1997 Nov 14; 30(5):632-42. PubMed ID: 9388046
    [Abstract] [Full Text] [Related]

  • 36. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
    Rousso P, Buclin T, Nussberger J, Décosterd LA, La Roche SD, Brunner-Ferber F, Brunner HR, Biollaz J.
    J Hypertens; 1999 Mar 14; 17(3):427-37. PubMed ID: 10100082
    [Abstract] [Full Text] [Related]

  • 37. Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme.
    Kukkola PJ, Savage P, Sakane Y, Berry JC, Bilci NA, Ghai RD, Jeng AY.
    J Cardiovasc Pharmacol; 1995 Mar 14; 26 Suppl 3():S65-8. PubMed ID: 8587470
    [Abstract] [Full Text] [Related]

  • 38. Effects of metalloprotease inhibitors on the conversion of proendothelin-1 to endothelin-1.
    Trapani AJ, Balwierczak JL, Lappe RW, Stanton JL, Graybill SC, Hopkins MF, Savage P, Sperbeck DM, Jeng AY.
    Biochem Mol Biol Int; 1993 Dec 14; 31(5):861-7. PubMed ID: 8136704
    [Abstract] [Full Text] [Related]

  • 39. Effect of phosphoramidon (endothelin converting enzyme inhibitor) and BQ-123 (endothelin receptor subtype A antagonist) on blood pressure in hypertensive rats.
    McMahon EG, Palomo MA, Brown MA, Bertenshaw SR, Carter JS.
    Am J Hypertens; 1993 Aug 14; 6(8):667-73. PubMed ID: 8217029
    [Abstract] [Full Text] [Related]

  • 40. Effects of benazepril, an angiotensin-converting enzyme inhibitor, combined with CGS 35066, a selective endothelin-converting enzyme inhibitor, on arterial blood pressure in normotensive and spontaneously hypertensive rats.
    Battistini B, Ayach B, Molez S, Blouin A, Jeng AY.
    Clin Sci (Lond); 2002 Aug 14; 103 Suppl 48():363S-366S. PubMed ID: 12193123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.